About
MRNA treatments
Areas of Focus
Categories
Gene Therapy, RNA & Peptide Therapy
Clinical Trials (26)
View allTotal Trials
26
As Lead Sponsor
18
As Collaborator
8
Total Enrollment
46,582
By Phase
PHASE1: 11PHASE2: 3PHASE1/PHASE2: 7PHASE3: 4PHASE2/PHASE3: 1
By Status
COMPLETED: 16TERMINATED: 5WITHDRAWN: 2NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline26 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT07073183Lead Sponsor
Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)
PHASE1Not yet recruiting
36 participants
Started: Jul 30, 2025 · Completed: Dec 31, 2029
NCT05960097Collaborator
A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults
PHASE2Completed
692 participants
Started: Aug 1, 2023 · Completed: Aug 30, 2024
NCT05938387Lead Sponsor
Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or Astrocytoma
PHASE1Active, not recruiting
37 participants
Started: Jun 1, 2023 · Completed: Feb 4, 2026
NCT05823974Collaborator
A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults
PHASE1/PHASE2Completed
1,275 participants
Started: Apr 27, 2023 · Completed: Dec 18, 2024
NCT05446740Collaborator
A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults
PHASE1Completed
324 participants
Started: Aug 9, 2022 · Completed: Mar 26, 2024
Locations (1)
Headquarters
Tübingen, Germany
Map
Loading map...